SUBSCRIBE
SUBSCRIBE
Roxanne Nelson

Roxanne Nelson

Freelance writer

Roxanne Nelson is a registered nurse and an award-winning medical writer who has written for many major news outlets and publications.

GLP-1 injector pens and pills against colorful background
Weight loss
5 Startups Looking to Compete in the Obesity Space
With GLP-1 receptor agonists expected to dominate the weight loss market in the near term, several young companies are building on this mechanism, while others are taking a completely different approach.
July 22, 2024
 · 
5 min read
 · 
Roxanne Nelson
Illustration of ADCs and 100-dollar bills
Deals
5 Major ADC Deals This Year Highlight Investment Uptick
In 2023, the ADC market exceeded $10 billion, and this momentum is persisting into 2024, as evidenced by several strategic deals and a robust pipeline of candidate drugs.
July 2, 2024
 · 
3 min read
 · 
Roxanne Nelson
Deals
5 Major ADC Deals This Year Highlight Investment Uptick
In 2023, the ADC market exceeded $10 billion, and this momentum is persisting into 2024, as evidenced by several strategic deals and a robust pipeline of candidate drugs.
June 30, 2024
 · 
4 min read
 · 
Roxanne Nelson
Pictured: Collage of Capital building, money, and gavel
Drug Delivery
BMS, J&J Losses Not the End of IRA Legal Battle
With appeals and additional cases still pending, it remains to be seen if any of the arguments being brought by biopharma companies against the U.S. government will hold up in court.
May 7, 2024
 · 
5 min read
 · 
Roxanne Nelson
Pictured: A pharmacist looking at a tablet in fron
Policy
Medicare Negotiations Unlikely to Cause Financial Losses—At Least for Now
With several of the first 10 selected drugs facing patent expirations and generic competition, the drug price negotiations dictated by the IRA may not greatly affect revenues. But that could change quickly.
September 5, 2023
 · 
4 min read
 · 
Roxanne Nelson